Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a

Claudia Cifuentes1, Milton Lombana2, Henry Vargas3

  • 1Clinical Oncology Department, Hospital Universitario Mayor de Mederi, Bogotá, Colombia.

Summary

Comprehensive genomic profiling (CGP) using next-generation sequencing (NGS) identified actionable mutations in over 46% of solid tumors. This approach can guide personalized cancer therapy and improve patient outcomes in developing countries.